UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549

                                FORM 8-K

                                 CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934



Date of Report (Date of earliest event reported)    September 13, 2005



                           BIOPHAN TECHNOLOGIES, INC.
                  --------------------------------------------
             (Exact name of registrant as specified in its charter)


            Nevada                 0-26057               82-0507874
-----------------------------   -------------            -----------
(State or other jurisdiction     (Commission           (I.R.S. Employer
      of incorporation)          File Number)         Identification No.)


      150 Lucius Gordon Drive,  Suite 215
            West Henrietta, New York                     14586
      ---------------------------------------          ---------
      (Address of principal executive offices)         (Zip code)



                             (585) 214-2441
                         -------------------------
                         (Registrant's telephone number)

<PAGE>

Item 7.01 Regulation FD Disclosure

On September 13, 2005, we issued a press release announcing the signing of a
Letter of Intent with MYOTECH, LLC to acquire the rights to MYOTECH'S cardiac
assist device technology, to direct the development, regulatory approval and
marketing of that technology and to acquire a minority interest in MYOTECH. The
press release is filed herewith as Exhibit 99.1 and is incorporated herein by
reference.

Item 9.01 Financial Statements and Exhibits

(c) Exhibits

Number   Exhibit
------   -------

99.1     Press Release dated September 13, 2005: Biophan to Acquire Rights to
         Proprietary Cardiac Assist Device Technology Developed by
         MYOTECH, LLC.



                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                                 BIOPHAN TECHNOLOGIES, INC.
                                                 --------------------------
                                                        (Registrant)


Date    9/13/05                                  /S/ Robert J. Wood
    ----------------                             --------------------------
                                                        (Signature)

                                                 Robert J. Wood
                                                 CFO, Treasurer, Secretary
                                                 (Principal Financial Officer)
{"company-data": {"conformed-name": "BIOPHAN TECHNOLOGIES INC", "cik": "0001084000", "assigned-sic": "3841", "irs-number": "820507874", "state-of-incorporation": "NV", "fiscal-year-end": "0228"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-26057", "film-number": "051082751"}, "business-address": {"street1": "150 LUCIUS GORDON DR", "street2": "STE 215", "city": "WEST HENRIETTA", "state": "NY", "zip": "14586", "phone": "5852142441"}, "mail-address": {"street1": "150 LUCIUS GORDON DR", "street2": "STE 215", "city": "WEST HENRIETTA", "state": "NY", "zip": "14586"}, "former-company": {"former-conformed-name": "GREATBIO TECHNOLOGIES INC", "date-changed": "20001215"}}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                          Washington, D.C. 20549

                                FORM 8-K

                                 CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported)    September 13, 2005

                           BIOPHAN TECHNOLOGIES, INC.
                  --------------------------------------------
             (Exact name of registrant as specified in its charter)

            Nevada                 0-26057               82-0507874
-----------------------------   -------------            -----------
(State or other jurisdiction     (Commission           (I.R.S. Employer
      of incorporation)          File Number)         Identification No.)

      150 Lucius Gordon Drive,  Suite 215
            West Henrietta, New York                     14586
      ---------------------------------------          ---------
      (Address of principal executive offices)         (Zip code)

                             (585) 214-2441
                         -------------------------
                         (Registrant's telephone number)
Item 7.01 Regulation FD Disclosure

On September 13, 2005, we issued a press release announcing the signing of a
Letter of Intent with MYOTECH, LLC to acquire the rights to MYOTECH'S cardiac
assist device technology, to direct the development, regulatory approval and
marketing of that technology and to acquire a minority interest in MYOTECH. The
press release is filed herewith as Exhibit 99.1 and is incorporated herein by
reference.

Item 9.01 Financial Statements and Exhibits

(c) Exhibits

Number   Exhibit
------   -------

99.1     Press Release dated September 13, 2005: Biophan to Acquire Rights to
         Proprietary Cardiac Assist Device Technology Developed by
         MYOTECH, LLC.

                                   SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                                 BIOPHAN TECHNOLOGIES, INC.
                                                 --------------------------
                                                        (Registrant)

Date    9/13/05                                  /S/ Robert J. Wood
    ----------------                             --------------------------
                                                        (Signature)

                                                 Robert J. Wood
                                                 CFO, Treasurer, Secretary
                                                 (Principal Financial Officer)